AIC
CTMX icon

AWM Investment Company’s CytomX Therapeutics CTMX Stock Holding History

AWM Investment Company’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$705K Buy
+150,000
New +$761K 0.08% 92

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AWM Investment Company's CTMX Position: Q1 2026 in Review

AWM Investment Company opened a new position in CytomX Therapeutics (CTMX) in Q1 2026: 150,000 shares worth $705K. The stake represents 0.08% of the portfolio and ranks #92 among its holdings.

179 funds tracked by Wall St. Rank hold CTMX as of Q1 2026.

  • AWM Investment Company held 150,000 shares of CytomX Therapeutics worth $705K as of Q1 2026.
  • CytomX Therapeutics was a new AWM Investment Company position in Q1 2026.
  • CytomX Therapeutics made up 0.08% of AWM Investment Company's portfolio in Q1 2026, its #92 holding.
  • 179 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.